Ramiro Sanchez, Chief Medical Officer at Cerevel Therapeutics Holdings, Inc. (CERE), sold 7,500 shares at $41.39 ($310K) on 2023-12-15, disclosed to the SEC on 2023-12-19.
Open-market sale of $310k CERE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CERE | SELL | 2023-12-11 | $414K | — | Filing → |